SPOTLIGHT Webinar 2025: Jemperli + chemo in advanced/recurrent pMMR endometrial cancer patients
Har du spørsmål om JEMPERLI for dine pasienter? Kontakt oss
Jemperli trademark is a registered trademark of the GSK group of companies.
© 2025 GSK group of companies or its licensor.